DK315889D0 - Antivirale kombinationer, forbindelser der kan anvendes heri, og farmaceutiske praeparater med indhold af saadanne kombinationer. - Google Patents

Antivirale kombinationer, forbindelser der kan anvendes heri, og farmaceutiske praeparater med indhold af saadanne kombinationer.

Info

Publication number
DK315889D0
DK315889D0 DK315889A DK315889A DK315889D0 DK 315889 D0 DK315889 D0 DK 315889D0 DK 315889 A DK315889 A DK 315889A DK 315889 A DK315889 A DK 315889A DK 315889 D0 DK315889 D0 DK 315889D0
Authority
DK
Denmark
Prior art keywords
combinations
pharmaceutical preparations
antiviral
preparations containing
relationships used
Prior art date
Application number
DK315889A
Other languages
English (en)
Other versions
DK315889A (da
Inventor
Todd Andrew Blumenkopf
Thomas Spector
Devron Randolph Averett
Jr Robert William Morrison
Eric Cleveland Bigham
Virgil Lee Styles
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK315889D0 publication Critical patent/DK315889D0/da
Publication of DK315889A publication Critical patent/DK315889A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK315889A 1988-06-27 1989-06-26 Antivirale kombinationer, forbindelser der kan anvendes heri, og farmaceutiske praeparater med indhold af saadanne kombinationer. DK315889A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888815241A GB8815241D0 (en) 1988-06-27 1988-06-27 Antiviral combinations & compounds therefor

Publications (2)

Publication Number Publication Date
DK315889D0 true DK315889D0 (da) 1989-06-26
DK315889A DK315889A (da) 1989-12-28

Family

ID=10639423

Family Applications (1)

Application Number Title Priority Date Filing Date
DK315889A DK315889A (da) 1988-06-27 1989-06-26 Antivirale kombinationer, forbindelser der kan anvendes heri, og farmaceutiske praeparater med indhold af saadanne kombinationer.

Country Status (19)

Country Link
US (3) US5175165A (da)
EP (1) EP0349243B1 (da)
JP (1) JPH0245423A (da)
KR (1) KR910000149A (da)
AT (1) ATE74276T1 (da)
AU (1) AU626304B2 (da)
DE (1) DE68901111D1 (da)
DK (1) DK315889A (da)
ES (1) ES2031357T3 (da)
FI (1) FI893112A (da)
GB (1) GB8815241D0 (da)
GR (1) GR3005067T3 (da)
HU (1) HU206264B (da)
IE (1) IE64496B1 (da)
IL (1) IL90750A0 (da)
MY (1) MY106304A (da)
NZ (1) NZ229711A (da)
PT (1) PT90972B (da)
ZA (1) ZA894835B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8815241D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Antiviral combinations & compounds therefor
US5164395A (en) * 1988-06-27 1992-11-17 Burroughs Wellcome Co. Antiviral acetyl pyridine derivative or said acetyl pyridine derivative in combination with acyclovir
US5674849A (en) * 1990-10-24 1997-10-07 Allelix Biopharmaceuticals Inc. Anti-viral compositions
CA2033447C (en) * 1990-12-31 1999-08-31 Robert Deziel Synergistic combination for treating herpes infections
CA2033448C (en) * 1990-12-31 1996-11-26 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes compositions and method of use
US5879700A (en) * 1991-10-15 1999-03-09 Hostetler; Karl Y. Nucleoside analogue phosphates for topical use
US5580571A (en) * 1991-10-15 1996-12-03 Hostetler; Karl Y. Nucleoside analogues
US6015573A (en) * 1993-05-12 2000-01-18 Hostetler; Karl Y. Nucleoside phosphate therapy for viral infection
CA2162574A1 (en) * 1993-05-12 1994-11-24 Karl Y. Hostetler Acyclovir derivatives for topical use
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
GB9315755D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized formulation
AU2768295A (en) * 1994-07-11 1996-02-09 Hoechst Marion Roussel, Inc. Method of treating a neoplastic disease state by conjunctive therapy with 2'-fluoromethylidene derivatives and radiation or chemotherapy
US5693791A (en) * 1995-04-11 1997-12-02 Truett; William L. Antibiotics and process for preparation
NZ311319A (en) * 1995-06-07 2000-01-28 Trimeris Inc The treatment of HIV and other viral infections using the peptide DP-178 or DP-107 in combination therapy
US20030212051A1 (en) * 2001-04-06 2003-11-13 Polli James E Bile acid containing prodrugs with enhanced bioavailabilty
MXPA06013295A (es) 2004-05-19 2007-02-22 Emisphere Tech Inc Formulaciones de aciclovir.
JP4972062B2 (ja) * 2008-03-17 2012-07-11 メディヴィル・アクチエボラーグ 抗ウイルス製剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
US4777166A (en) * 1982-03-30 1988-10-11 The United States Of America As Represented By The Secretary Of The Army 2-acetylpyridine thiosemicarbazone compositions as anitviral agents
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
GB8320308D0 (en) * 1983-07-28 1983-09-01 Wellcome Found Antiviral combinations
US4606917A (en) * 1984-10-03 1986-08-19 Syntex (U.S.A) Inc. Synergistic antiviral composition
US4751221A (en) * 1985-10-18 1988-06-14 Sloan-Kettering Institute For Cancer Research 2-fluoro-arabinofuranosyl purine nucleosides
US4829055A (en) * 1987-01-23 1989-05-09 Naficy Sadeque S Method of treatment for herpes infections of external tissues
GB8815241D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Antiviral combinations & compounds therefor
GB8823319D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds
GB8823320D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds

Also Published As

Publication number Publication date
JPH0245423A (ja) 1990-02-15
ES2031357T3 (es) 1992-12-01
DE68901111D1 (de) 1992-05-07
HUT52379A (en) 1990-07-28
ZA894835B (en) 1991-02-27
EP0349243A2 (en) 1990-01-03
GR3005067T3 (da) 1993-05-24
PT90972A (pt) 1989-12-29
MY106304A (en) 1995-04-29
GB8815241D0 (en) 1988-08-03
US5021437A (en) 1991-06-04
KR910000149A (ko) 1991-01-29
IE892060L (en) 1989-12-27
US5393883A (en) 1995-02-28
AU626304B2 (en) 1992-07-30
NZ229711A (en) 1992-08-26
ATE74276T1 (de) 1992-04-15
DK315889A (da) 1989-12-28
HU206264B (en) 1992-10-28
EP0349243B1 (en) 1992-04-01
IL90750A0 (en) 1990-01-18
EP0349243A3 (en) 1990-07-11
US5175165A (en) 1992-12-29
AU3702689A (en) 1990-02-01
FI893112A (fi) 1989-12-28
PT90972B (pt) 1995-01-31
FI893112A0 (fi) 1989-06-26
IE64496B1 (en) 1995-08-09

Similar Documents

Publication Publication Date Title
DK315889A (da) Antivirale kombinationer, forbindelser der kan anvendes heri, og farmaceutiske praeparater med indhold af saadanne kombinationer.
DK0686151T3 (da) Substituerede cycliske carbonylforbindelser og derivater deraf, der kan anvendes som retrovirale proteaseinhibitorer
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
NO306720B1 (no) Sykliske ureaer og analoger som er anvendbare som retrovirale proteaseinhibitorer, farmasöytiske preparater omfattende disse og anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
DK0810209T3 (da) Alpha - and beta-aminosyre-hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser
ES2160046A1 (es) Derivados pentapeptidicos.
MX9603909A (es) Derivados de sulfonamida como inhibidores de proteasa aspartilo.
EP0677048A1 (en) CYCLIC SULPHONES AS INHIBITORS RETROVIRAL PROTEASES.
BR9105737A (pt) Processo para reduzir a contaminacao de um produto de amplificacao,conjunto para uso em um tipo de procedimento de amplificacao e processo para amplificar uma sequencia de amplificacao de uma sequencia-alvo
DK0973735T3 (da) Polyaromatiske antivirale præparater
DK0885881T3 (da) Sulfonylalkanoylaminohydroxyethylaminosulfaminsyrer, der er anvendelige som retrovirale proteaseinhibitorer
ATE130315T1 (de) Hirudin-derivate mit verzögerter wirkung.
DK0610078T3 (da) Cytotoksisk og antiviral forbindelse.
DK0604186T3 (da) HIV-proteaseinhibitorer, som er egnede til behandling af AIDS
GR3023044T3 (en) Succinoylamino hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors.
ES2065951T3 (es) Uso de un inhibidor de prolilendopeptidasa para el tratamiento del sida.
ES2108254T3 (es) Composicion del inhibidor de infeccion con virus del sida.
ES2062266T3 (es) Uso de quinolil- e isoquinoliloxazol-2-onas para la obtencion de un medicamento destinado para la prevencion de infecciones por virus envueltos por glicoproteinas.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment